P686: Opportunistic screening for broad range of clinically relevant secondary findings: Outcomes of exome analysis in the Incidental Genomics RCT

Practice is shifting towards use of exome and genome sequencing, offering the opportunity to expand analyses beyond variants related to the primary diagnostic indication to identify secondary findings (SFs). While medically actionable SFs are prioritized by guidelines, a much broader spectrum of results could be analyzed, aligned with patients' preferences. We characterized the outcomes of analyzing a broad range of clinically relevant SFs from exome sequencing in the Incidental Genomics RCT (NCT03597165), and the laboratory resources required for sequence analysis.

Authors

Institutions

Publication Details

Journal
Genetics in Medicine Open
Published
2025-01-01
DOI
https://doi.org/10.1016/j.gimo.2025.103055
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P686: Opportunistic screening for broad range of clinically relevant secondary findings: Outcomes of exome analysis in the Incidental Genomics RCT

Sonya Grewal, Daena Hirjikaka, Kelvin Chan, Yael Silberman et al.
1 links
Genetics in Medicine Open
Genomics and Rare Diseases
article

P686: Opportunistic screening for broad range of clinically relevant secondary findings: Outcomes of exome analysis in the Incidental Genomics RCT

Sonya Grewal, Daena Hirjikaka, Kelvin Chan, Yael Silberman, Kasmintan A. Schrader, Kevin E. Thorpe, Yvonne Bombard, Rita Kodida, Thomas Ward, Jordan P. Lerner‐Ellis, Susan Randall Armel, Tracy Graham, Chantal F. Morel, Salma Shickh, Christine Elser, Abdul Noor, José‐Mario Capo‐Chichi, Raymond H. Kim, Iris Cohn, Andrea Eisen, Marc Clausen, Carolyn Piccinin, Emily Glogowski, Elena Greenfeld, Melyssa Aronson, Jordan Sam, Seema Panchal, Emma Reble, Chloe Mighton, Larissa Peck
article en

Abstract

Practice is shifting towards use of exome and genome sequencing, offering the opportunity to expand analyses beyond variants related to the primary diagnostic indication to identify secondary findings (SFs). While medically actionable SFs are prioritized by guidelines, a much broader spectrum of results could be analyzed, aligned with patients' preferences. We characterized the outcomes of analyzing a broad range of clinically relevant SFs from exome sequencing in the Incidental Genomics RCT (NCT03597165), and the laboratory resources required for sequence analysis.

Genetics in Medicine OpenVol. 3
Broad Institute (US), Sunnybrook Health Science Centre (CA), University Health Network (CA), University of Toronto (CA), Juravinski Cancer Centre (CA), Hospital for Sick Children (CA), Health Sciences Centre (CA), Health Net (US), Sanofi (Belgium) (BE), Sinai Health System (US), Unity Health Toronto
Openalex Percentile: Top 94%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.